Shopping Cart
- Remove All
Your shopping cart is currently empty
A-770041
🥰Excellent
Catalog No. T14074Cas No. 869748-10-7
Alias A770041, A 770041
A-770041 is an orally active and selective Lck inhibitor that inhibits concanavalin A-stimulated IL-2 production in whole blood and prevents cardiac allograft rejection. A-770041 reduces pulmonary fibrosis by inhibiting TGF-β production in regulatory T cells.
A-770041
🥰Excellent
Purity: 99.86%
Catalog No. T14074Alias A770041, A 770041Cas No. 869748-10-7
A-770041 is an orally active and selective Lck inhibitor that inhibits concanavalin A-stimulated IL-2 production in whole blood and prevents cardiac allograft rejection. A-770041 reduces pulmonary fibrosis by inhibiting TGF-β production in regulatory T cells.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $67 | In Stock | |
| 5 mg | $112 | In Stock | |
| 10 mg | $188 | In Stock | |
| 25 mg | $427 | In Stock | |
| 50 mg | $725 | In Stock | |
| 100 mg | $1,130 | In Stock | |
| 200 mg | $1,500 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $153 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreBatch Information
Select Batch
Purity:99.86%
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | A-770041 is an orally active and selective Lck inhibitor that inhibits concanavalin A-stimulated IL-2 production in whole blood and prevents cardiac allograft rejection. A-770041 reduces pulmonary fibrosis by inhibiting TGF-β production in regulatory T cells. |
| Targets&IC50 | Lck:0.147 μM, Src:9.1 μM, FGR:14.1 μM, Fyn:44.1 μM |
| In vitro | A-770041 selectively inhibited LCK with IC50=0.147 μM; A-770041 inhibited other SRC family kinases with SRC IC50=9.1 μM, FGR IC50=14.1 μM, and FYN IC50=44.1 μM. [1] A-770041 dose-dependently (0-30 μM; 2 h) inhibited anti-CD3-induced IL-2 production with an EC50 = 80 nM. [1] |
| In vivo | Recipient animals were treated with vehicle control or 2.5 to 20 mg/kg/day of A-770041 in equally. Animals were treated for 14 days, and graft viability was assessed by abdominal palpation each day. A-770041 dosed at 2.5 mg/kg/day did not lengthen graft survival time. There was a dose-dependent increase in survival with doses of 5 and 10 mg/kg/day. At doses of 10 and 20 mg/kg/day of A-770041, 100% of transplanted grafts were still beating at 14 days. [1] |
| Synonyms | A770041, A 770041 |
| Molecular Weight | 621.73 |
| Formula | C34H39N9O3 |
| Cas No. | 869748-10-7 |
| Smiles | NC1=C2C(=NN(C2=NC=N1)[C@H]3CC[C@@H](CC3)N4CCN(C(C)=O)CC4)C5=CC(OC)=C(NC(=O)C6=CC=7C(N6C)=CC=CC7)C=C5 |
| Relative Density. | 1.42 g/cm3 (Predicted) |
Storage & Solubility Information
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL(32.17 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy A-770041 | purchase A-770041 | A-770041 cost | order A-770041 | A-770041 chemical structure | A-770041 in vivo | A-770041 in vitro | A-770041 formula | A-770041 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.